62 results on '"Vrablik, M."'
Search Results
2. Analysis of hypertriglyceridemic gene score in patients with familial dysbetalipoproteinemia
3. Cell-free DNA as an potential marker of statin induced muscle injury
4. Triglycerides, polymorphisms and the risk of acute coronary syndrome in the Czech population
5. APOA5, GCKR, LRP1 AND MAP3K1 polymorphisms and the risk of acute coronary syndrome in the Czech population
6. Performance of various diagnostic criteria of familial dysbetalipoproteinemia in ApoE2/E2 homozygotes with mixed dyslipidaemia
7. Characteristics of patients with uncontrolled arterial hypertension and/or dyslipidemia – Lipitenclidec study
8. Are risk-based LDL-c goals achieved in primary and secondary care in central and Eastern Europe? comparison with other Europe regions from the DA VINCI observational study
9. Clinical and laboratory characteristics of patients with uncontrolled dyslipidaemia and/or arterial hypertension in clinical practice in the Czech Republic
10. Plasmocellular Myeloma As A Cause Of Severe Mixed Dyslipidemia Accompanied By Hyperviscosity Syndrome
11. Efficacy And Safety Of Fixed-Dose Combinations Of Rosuvastatin And Ezetimibe Versus Rosuvastatin Monotherapy In Patients With Primary Hypercholesterolaemia Inadequately Controlled On Statin Therapy
12. The Effectiveness Of Life-Style Counselling In Patients With Atherogenic Dyslipidemia On Lipid Profile And Atherosclerosis Risk
13. Dyslipidemia Control In Primary Care In The Czech Republic
14. Gene score as predictor of hypertriglyceridemia in Czech population
15. General characteristics of pacients with homozygous form of familial hypercholesterolaemia in the Czech Republic
16. Familial dysbetalipoproteinemia – yes, or no? – Retrospective patient study of the center for preventive cardiology of the 3rd internal clinic first faculty of medicine and general university hospital
17. Effect of APOE genotype on LDL cholesterol levels in FH and FDB patients: Is there sex-specifically protective genotype?
18. High prevalence of CVD risk factors and unsatisfactory control of LDL-C levels in 40-years-old men and 50-years-old women in the Czech Republic
19. Gene variants at FTO, 9p21, and 2q36.3 are age-independently associated with myocardial infarction in Czech men.
20. FTO and MC4R gene variants determine BMI changes in children after intensive lifestyle intervention
21. Type III hyperlipidaemia in patient with apo E2* (Arg136→Cys)/3 genotype
22. The independent correlation of the impact of lipoprotein(a) levels and apolipoprotein E polymorphism on carotid artery intima thickness
23. Increase levels of soluble cell adhesion molecules (sE-Selectin, sP-Selectin and sICAM-1) in overweight adults with combined hyperlipidemia
24. ROSIGLITAZONE AND FENOFIBRATE IMPROVE HDL METABOLISM ASSESSED BY FERHDL
25. W16-P-025 Changes of plasma atherosclerosis risk factors' levels caused by estrogen replacement therapy
26. APOA5 haplotypes determine triglyceride decrease after lifestyle induced weight loss in children.
27. 630 PHARMACOGENETICS OF STATIN TREATMENT EFFICACY: ANALYSIS OF GENETIC VARIATION AT EIGHT CANDIDATE GENE LOCI
28. Abstract: P358 APOLIPOPROTEIN A5 AND E GENE VARIANTS DETERMINE THE EFFICACY OF STATIN TREATMENT
29. IMPACT OF APOLIPOPROTEIN A5 GENE VARIANTS ON STATIN TREATMENT EFFICACY
30. PO22-705 ESTROGEN REPLACEMENT THERAPY LOWERS RLP CONCENTRATION: ORAL AND TRANSDERMAL ADMINISTRATION COMPARED
31. PO6-168 APOLIPOPROTEIN AV GENE SNPS DETERMINATION IN PATIENTS GROUP WITH HIGH TRIGLYCERIDES LEVELS
32. We-P12:278 Estrogen replacement therapy decreases RLP concentration in plasma: Oral and transdermal ERT comparison
33. We-P11:117 Rosiglitazone improves quality of lipoproteins in patients with type 2 diabetes
34. W06-P-009 Type V hyperlipoproteinaemia: APOAVpolymorphism as genetic background
35. W06-P-006 Apolipoprotein AV gene SNP determination in patients with high triglyceride levels
36. W06-O-003 APOE and APOAV polymorphisms — Nointeraction in hypertriglyceridaemia
37. M.680 Age and triglyceride levels are predictors of vascular complications in patients with familial hypercholesterolemia
38. M.509 Sequential hormone replacement therapy in perimenopause and its influence on plasma lipids and other metabolic markers
39. W01.30 Apolipoprotein AV gene SNPs in patients with high triglyceride levels
40. 3P-0795 Apolipoprotein AV polymorphism is the only genetic marker associated with severe hypertriglyceridemia. Results of analysis of four gene loci
41. Mo-P6:430 Lipoprotein (A), its relation to gene control regions
42. The molecular basis of familial hypercholesterolemia in the Czech Republic – More homozygotes revealed by DNA testing.
43. Abstract: P372 AN INTERPLAY BETWEEN A COMMON ABCA1 POLYMORPHISM AND APOE ISOFORMS IN HDL LEVELS DETERMINATION
44. T04-P-048 Liprotein (a), its relation to plasmalipids and other risk factors for atherosclerosis
45. W06-P-008 APOAV variant ALA315> VAL has no effecton plasma triacylglycerols in a Czech male cohort
46. FH homozygote without cardiovascular disease at the age of 40.
47. LIPID PROFILE AND LP(A) IN FIT AND HEALTHY ELDERLY
48. CARDIOVASCULAR RISK ASSESSMENT BY ATHEROGENIC INDEX OF PLASMA [LOG(TG/HDL-C)]
49. PO6-175 CONTROL GENE REGIONS OF LIPOPROTEIN (A): ASSOCIATION WITH LONGEVITY
50. Mo-P6:420 Two novel APOA5 missense mutations in patients with severe hypertriglyceridemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.